The variant was 27 times more likely to break through Pfizer protection from January-February and cause symptoms than it was to penetrate natural immunity from the same period
NATHAN JEFFAY | TIMES OF ISRAEL
Natural immunity from contracting coronavirus provided Israelis with longer-lasting protection against the Delta variant than two shots of the Pfizer vaccine given early this year, new Israeli research suggests.
🕊️📖 If this teaching has increased your faith and edified you - and the Holy Spirit moves you – please offfer your support to: https://www.stephendarbyministries.com/ 📖🕊️
🕊️📖 If this teaching has increased your faith and edified you - and the Holy Spirit moves you – please offfer your support to: https://www.stephendarbyministries.com/ 📖🕊️
🕊️📖 If this teaching has increased your faith and edified you - and the Holy Spirit moves you – please offfer your support to: https://www.stephendarbyministries.com/ 📖🕊️
A bone-marrow plasma cell (artificially coloured). Such cells, which produce antibodies, linger for months in the bodies of people who have recovered from COVID-19.Credit: Dr Gopal Murti/Science Photo Library
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer.
Ewen Callaway | THE JOURNAL NATURE
Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. So suggest researchers who have identified long-lived antibody-producing cells in the bone marrow of people who have recovered from COVID-191.
The study provides evidence that immunity triggered by SARS-CoV-2 infection will be extraordinarily long-lasting.
🕊️📖 If this teaching has increased your faith and edified you - and the Holy Spirit moves you – please offfer your support to: https://www.stephendarbyministries.com/ 📖🕊️
